NCT04051203View on ClinicalTrials.gov

Ultrasound Guided Platelet Rich Plasma Injections for Post Traumatic Greater Occipital Neuralgia

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions
Occipital NeuralgiaHeadache
Interventions
BIOLOGICAL

Autologous Platelet Rich Plasma Injection

60mL of blood will be drawn from the antecubital vein and processed via centrifugation. Samples will be centrifuged as per manufacturer instructions, yielding 5mL of PRP.

DRUG

Depo-Medrol and lidocaine

Steroid injections will be prepared to include 20mg Depo-Medrol and 2mL 2% lidocaine.

OTHER

Normal Saline

2mL normal saline.

Trial Locations (1)

T2N2T9

Foothills Medical Center, Main Floor Special Services, Calgary

All Listed Sponsors
lead

University of Calgary

OTHER

NCT04051203 - Ultrasound Guided Platelet Rich Plasma Injections for Post Traumatic Greater Occipital Neuralgia | Biotech Hunter | Biotech Hunter